<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on September 20, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/ct2/show/NCT03304860</url>
  </required_header>
  <id_info>
    <org_study_id>17-00570</org_study_id>
    <nct_id>NCT03304860</nct_id>
  </id_info>
  <brief_title>Child-Physician Recommendation on Parental Adherence to Colorectal Cancer Screening</brief_title>
  <official_title>Child-Physician Recommendation on Parental Adherence to Colorectal Cancer Screening</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NYU Langone Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>NYU Langone Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Physician recommendation has been shown to be one of the most significant predictors for&#xD;
      colorectal cancer (CRC) screening. This study aims to identify the amount of parents of&#xD;
      internal medicine residents at NYU who are eligible for CRC screening but have not received&#xD;
      it. Investigators will perform an intervention and quantify the amount of parents eligible&#xD;
      for CRC screening after the intervention. This study will entail sending 2 brief surveys (one&#xD;
      before the intervention and one after) which determine if the parents of the residents are&#xD;
      eligible for CRC screening. The intervention will be asking the residents with eligible&#xD;
      parents to have a discussion with their parents about CRC screening options and to address&#xD;
      their concerns. Investigators will provide a one page document the residents can give their&#xD;
      parents as a reference as part of the intervention.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 1, 2017</start_date>
  <completion_date type="Actual">July 1, 2018</completion_date>
  <primary_completion_date type="Actual">July 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in CRC screening rate of eligible parents of internal medicine residents at NYU from before to after the intervention</measure>
    <time_frame>Baseline to 6 Months</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">59</enrollment>
  <condition>Colorectal Cancer</condition>
  <arm_group>
    <arm_group_label>CRC screening Survey</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Residents with parents eligible for CRC screening will be asked to provide their e-mail address, solely for the use of distributing the follow up survey so it can be linked to 2 brief (3-5 min) surveys</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Survey</intervention_name>
    <description>Survey with 4-7 questions about each parents' demographics and CRC screening history. Depending on answers, provided a CRC screening document and asked to discuss screening with parents, followed by a brief survey in 4 months</description>
    <arm_group_label>CRC screening Survey</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Internal medicine residents at NYU - PGY1, PGY2, and PGY3 during 2017-2018 academic&#xD;
             year&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark Pochapin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>NYU Langone Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>New York University School of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>October 4, 2017</study_first_submitted>
  <study_first_submitted_qc>October 4, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 9, 2017</study_first_posted>
  <last_update_submitted>November 6, 2018</last_update_submitted>
  <last_update_submitted_qc>November 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>


download date: ClinicalTrials.gov processed this data on September 20, 2023
link text: Link to the current ClinicalTrials.gov record.
url: https://clinicaltrials.gov/ct2/show/NCT03304860
org study id: 17-00570
nct id: NCT03304860
lead sponsor: 
has dmc: No
is fda regulated drug: No
is fda regulated device: No
Physician recommendation has been shown to be one of the most significant predictors for
      colorectal cancer (CRC) screening. This study aims to identify the amount of parents of
      internal medicine residents at NYU who are eligible for CRC screening but have not received
      it. Investigators will perform an intervention and quantify the amount of parents eligible
      for CRC screening after the intervention. This study will entail sending 2 brief surveys (one
      before the intervention and one after) which determine if the parents of the residents are
      eligible for CRC screening. The intervention will be asking the residents with eligible
      parents to have a discussion with their parents about CRC screening options and to address
      their concerns. Investigators will provide a one page document the residents can give their
      parents as a reference as part of the intervention.
allocation: N/A
intervention model: Single Group Assignment
primary purpose: Screening
masking: None (Open Label)
measure: Change in CRC screening rate of eligible parents of internal medicine residents at NYU from before to after the intervention
time frame: Baseline to 6 Months
arm group label: CRC screening Survey
arm group type: Experimental
description: Residents with parents eligible for CRC screening will be asked to provide their e-mail address, solely for the use of distributing the follow up survey so it can be linked to 2 brief (3-5 min) surveys
intervention type: Other
intervention name: Survey
description: Survey with 4-7 questions about each parents' demographics and CRC screening history. Depending on answers, provided a CRC screening document and asked to discuss screening with parents, followed by a brief survey in 4 months
arm group label: CRC screening Survey
criteria: 
gender: All
minimum age: 18 Years
maximum age: N/A
healthy volunteers: Accepts Healthy Volunteers
last name: Mark Pochapin, MD
role: Principal Investigator
affiliation: NYU Langone Health
facility: 
country: United States
responsible party type: Sponsor
mesh term: Colorectal Neoplasms
sharing ipd: No